Small Activating RNA (saRNA) Target Library
Description
Small Activating RNA (saRNA) is a synthetic RNA molecule that can activate gene expression by targeting specific promoter regions of genes and inducing their transcriptional activation. SBS Genetech's saRNA target library includes hundreds of validated activation targets for nearly a hundred genes, covering research hotspots related to tumorigenesis, inflammation and metabolism, and cell reprogramming. Additionally, we offer customized services for designing and synthesizing saRNA targets to activate genes in species such as humans, rats, and mice.
The saRNA activation targets have all been validated for effectiveness. You can refer to the Activity (Fold increase) values, select the corresponding saRNA-ID, and place an order for synthesis by emailing tech@sbsbio.com.
Gene | saRNA-ID | Condition studied | Activity (Fold increase) |
APOE | saRNA0333 | RNA activation study | 3.01 |
APOE | saRNA0398 | RNA activation study | 4.3 |
APOE | saRNA0400 | RNA activation study | 2.5 |
APOE | saRNA0401 | RNA activation study | 2.3 |
BCL2L12 | saRNA0329 | RNA activation study | 3.38 |
BCL2L12 | saRNA0334 | RNA activation study | 2.81 |
BCL2L12 | saRNA0336 | RNA activation study | 2.54 |
BRCA1 | saRNA0947 | saRNA mechanism and function study | High |
BRCA1 | saRNA0948 | saRNA mechanism and function study | High |
BRCA1 | saRNA0949 | saRNA mechanism and function study | High |
BRCA1 | saRNA0921 | saRNA mechanism and function study | High |
CALCA | saRNA0354 | RNA mechanism and function study | 1.47 |
Ccnb1 | saRNA0054 | RNA activation study | 5.7 |
Ccnb1 | saRNA0053 | RNA activation study | 3.4 |
Ccnb1 | saRNA0078 | RNA activation study | 3.4 |
Ccnb1 | saRNA0077 | RNA activation study | 1.5 |
CEBPA | saRNA0079 | saRNA aptamer delivery study | 6 |
CEBPA | saRNA1780 | Transcription activation study | 9 |
CEBPA | saRNA1725 | Transcription activation study | 2.8 |
CEBPA | saRNA1765 | Transcription activation study | 11 |
CIRBP | saRNA0331 | siRNA design for RNA activation | 3.18 |
CIRBP | saRNA0339 | siRNA design for RNA activation | 2.18 |
CIRBP | saRNA0340 | siRNA design for RNA activation | 2.17 |
cMyc | saRNA1975 | saRNA in cell reprogramming | 3.2 |
cMyc | saRNA1977 | saRNA in cell reprogramming | 2.3 |
cMyc | saRNA0346 | RNA function study | 1.77 |
cMyc | saRNA1008 | saRNA in cell reprogramming | 1.6 |
COX-2 | saRNA0779 | saRNA application study | 24 |
COX-2 | saRNA0780 | saRNA application study | 10 |
COX-2 | saRNA0796 | saRNA application study | 28 |
COX-2 | saRNA0795 | saRNA application study | 20 |
CXCR4 | saRNA0055 | RNA activation study | 1.2 |
CXCR4 | saRNA0056 | RNA activation study | 2.5 |
CXCR4 | saRNA0057 | RNA activation study | 2.6 |
CXCR4 | saRNA0059 | RNA activation study | 1.2 |
DPYSL3 | saRNA0161 | RNA activation study | 7.8 |
DPYSL3 | saRNA0157 | RNA activation study | 5.8 |
DPYSL3 | saRNA0207 | RNA activation study | 7.5 |
DPYSL3 | saRNA0203 | RNA activation study | 7 |
E-Cadherin | saRNA1679 | saRNA for anti-cancer | 22 |
E-Cadherin | saRNA1680 | saRNA for anti-cancer | 21 |
E-Cadherin | saRNA1681 | saRNA for anti-cancer | 22 |
E-Cadherin | saRNA1682 | saRNA for anti-cancer | 18 |
E-Cadherin | saRNA1650 | saRNA for anti-cancer/metastasis | High |
E-Cadherin | saRNA1651 | saRNA for anti-cancer/metastasis | High |
E-Cadherin | saRNA1656 | saRNA for anti-cancer/metastasis | High |
E-Cadherin | saRNA1657 | saRNA for anti-cancer/metastasis | High |
E-Cadherin | saRNA0015 | Transcription activation | 5 |
E-Cadherin | saRNA0016 | Transcription activation | 4.2 |
E-Cadherin | saRNA0014 | Transcription activation | 2 |
E-Cadherin | saRNA0017 | Transcription activation | 1.7 |
EGFP | saRNA0294 | saRNA and relation to nclRNA | 2.5 |
EGFP | saRNA0298 | saRNA and relation to nclRNA | 2 |
EGFP | saRNA0299 | saRNA and relation to nclRNA | 2 |
EGFP | saRNA0286 | saRNA and relation to nclRNA | 2 |
Foxg1 | saRNA0743 | saRNA for brain disorders | 2.8 |
Foxg1 | saRNA0744 | saRNA for brain disorders | 2.5 |
Foxg1 | saRNA0745 | saRNA for brain disorders | 1.6 |
Foxg1 | saRNA0746 | saRNA for brain disorders | 1.9 |
GAPD | saRNA0351 | RNA activation study | 1.52 |
GAPD | saRNA0367 | RNA activation study | 0.9 |
GAPD | saRNA0371 | RNA activation study | 0.57 |
GSN | saRNA0262 | RNA activation study | 11.5 |
GSN | saRNA0258 | RNA activation study | 6.5 |
GSN | saRNA0255 | RNA activation study | 4 |
GSN | saRNA0260 | RNA activation study | 14 |
H4k | saRNA0347 | RNA activation study | 1.75 |
H4k | saRNA0358 | RNA activation study | 1.31 |
H4k | saRNA0363 | RNA activation study | 1.12 |
HBB | saRNA0348 | RNA activation study | 1.68 |
HBB | saRNA0356 | RNA activation study | 1.34 |
HBB | saRNA0357 | RNA activation study | 1.32 |
HIC-1 | saRNA0268 | Gene activation via RNAa | 6.6 |
HIC-1 | saRNA0269 | Gene activation via RNAa | 1 |
HIC-1 | saRNA0270 | Gene activation via RNAa | 3.5 |
HIC-1 | saRNA0271 | Gene activation via RNAa | 1 |
HIC-1 | saRNA0455 | Anti-cancer transcription activation | 6.5 |
HIC-1 | saRNA0456 | Anti-cancer transcription activation | 1.2 |
HIC-1 | saRNA0460 | Anti-cancer transcription activation | 3.37 |
HIC-1 | saRNA0453 | Anti-cancer transcription activation | 1.2 |
HIC-1 | saRNA1581 | saRNA for anti-cancer/metastasis | 4.2 |
HIC-1 | saRNA1579 | saRNA for anti-cancer/metastasis | 4 |
HIC-1 | saRNA1576 | saRNA for anti-cancer/metastasis | 4.8 |
HIC-1 | saRNA1576 | saRNA for anti-cancer/metastasis | 4.8 |
HIC-1 | saRNA1574 | saRNA for anti-cancer/metastasis | 2.8 |
HIV | saRNA0350 | RNA activation study | 1.5 |
HIV | saRNA0366 | RNA activation study | 1 |
HIV | saRNA0369 | RNA activation study | 1 |
IL2 | saRNA0328 | RNA activation study | 3.3 |
IL2 | saRNA0383 | RNA activation study | 4.25 |
IL2 | saRNA0384 | RNA activation study | 4.5 |
IL2 | saRNA0380 | RNA activation study | 3.3 |
IL2 | saRNA0443 | RNA activation study | 6 |
IL2 | saRNA0444 | RNA activation study | 7.2 |
IL2 | saRNA0445 | RNA activation study | 8 |
IL2 | saRNA0446 | RNA activation study | 6.9 |
IL2 | saRNA0447 | RNA activation study | 8.2 |
IL2 | saRNA0448 | RNA activation study | 6.2 |
IL2 | saRNA0449 | RNA activation study | 16 |
IL6 | saRNA0338 | RNA activation study | 2.2 |
IL6 | saRNA0345 | RNA activation study | 1.7 |
NOS2 | saRNA1517 | saRNA activation application | 4 |
NOS2 | saRNA1518 | saRNA activation application | 6 |
NOS2 | saRNA1519 | saRNA activation application | 9 |
NOS2 | saRNA1936 | saRNA activation application | 3 |
NOS2 | saRNA1941 | saRNA activation application | 15 |
NOS2 | saRNA1943 | saRNA activation application | 4.4 |
NOS2 | saRNA1945 | saRNA activation application | 3 |
NOS2 | saRNA0973 | saRNA for anti-cancer/metastasis | 3 |
NOS2 | saRNA0977 | saRNA for anti-cancer/metastasis | 16 |
NOS2 | saRNA0979 | saRNA for anti-cancer/metastasis | 4.5 |
NOS2 | saRNA0981 | saRNA for anti-cancer/metastasis | 3 |
INS | saRNA0330 | RNA activation study | 3.2 |
INS | saRNA0394 | RNA activation study | 3.4 |
INS | saRNA0415 | RNA activation study | 3 |
INS | saRNA0419 | RNA activation study | 2.6 |
LDLR | saRNA0804 | saRNA mechanism and function | 2.6 |
LDLR | saRNA0805 | saRNA mechanism and function | 3 |
LDLR | saRNA0808 | saRNA mechanism and function | 2.1 |
LDLR | saRNA0825 | saRNA mechanism and function | 2.3 |
LDLR | saRNA0826 | saRNA mechanism and function | 2.5 |
LDLR | saRNA0827 | saRNA mechanism and function | 3.2 |
LDLR | saRNA0835 | saRNA mechanism and function | 3.5 |
LDLR | saRNA0836 | saRNA mechanism and function | 3 |
LDLR | saRNA0832 | saRNA mechanism and function | 2.7 |
LDLR | saRNA2004 | saRNA activation application | 2 |
LDLR | saRNA2000 | saRNA activation application | 2.6 |
LDLR | saRNA2001 | saRNA activation application | 3 |
LHB | saRNA0332 | RNA activation study | 3.16 |
LHB | saRNA0360 | RNA activation study | 1.25 |
mIl2 | saRNA0439 | RNA activation study | 2.8 |
mIl2 | saRNA0388 | RNA activation study | 1.3 |
MyoD | saRNA0253 | saRNA activation application | 4.5 |
NANOG | saRNA0586 | saRNA activation application | 3.1 |
NANOG | saRNA0587 | saRNA activation application | 4 |
NANOG | saRNA0588 | saRNA activation application | 4.7 |
NANOG | saRNA0589 | saRNA activation application | 4.3 |
NANOG | saRNA1981 | saRNA in cell reprogramming | 3.5 |
NANOG | saRNA1982 | saRNA in cell reprogramming | High |
NANOG | saRNA1980 | saRNA in cell reprogramming application | 2 |
NIS | saRNA1140 | saRNA in membrane transport proteins | 2.2 |
NIS | saRNA1125 | saRNA in membrane transport proteins | 2 |
NIS | saRNA1139 | saRNA in membrane transport proteins | 1.8 |
NKX3 | saRNA0070 | RNA activation study | 3.3 |
NKX3 | saRNA0071 | RNA activation study | 5.8 |
NKX3 | saRNA0045 | RNA activation study | 4.9 |
NKX3 | saRNA0047 | RNA activation study | 3.4 |
NKX3 | saRNA0477 | saRNA activation application | 6.3 |
NKX3 | saRNA0471 | saRNA activation application | 3.5 |
NKX3 | saRNA0468 | saRNA activation application | 3.8 |
NKX3 | saRNA0465 | saRNA activation application | 4.5 |
NKX3 | saRNA1910 | saRNA activation application | 4.5 |
NKX3 | saRNA1913 | saRNA activation application | 3.8 |
NKX3 | saRNA1922 | saRNA activation application | 6.4 |
NKX3 | saRNA1932 | saRNA activation application | High |
NPPA | saRNA0344 | siRNA design for RNA activation | 1.79 |
NPPA | saRNA0364 | siRNA design for RNA activation | 1.1 |
p21 | saRNA0024 | RNA activation study | 12.5 |
p21 | saRNA0026 | RNA activation study | 4.6 |
p21 | saRNA0027 | RNA activation study | 3.6 |
p21 | saRNA0025 | RNA activation study | 1 |
p21 | saRNA0037 | RNA activation study | 3.7 |
p21 | saRNA0061 | RNA activation study | 3.7 |
p21 | saRNA0062 | RNA activation study | 1 |
p21 | saRNA0569 | Anti-cancer transcription activation | 1.3 |
p21 | saRNA0570 | Anti-cancer transcription activation | 1.2 |
p21 | saRNA0571 | Anti-cancer transcription activation | 2.5 |
p21 | saRNA0567 | Anti-cancer transcription activation | 2.75 |
p21 | saRNA0598 | saRNA mechanism and function | 5 |
p21 | saRNA0604 | saRNA mechanism and function | 16 |
p21 | saRNA0605 | saRNA mechanism and function | 18 |
p21 | saRNA0606 | saRNA mechanism and function | 20 |
p21 | saRNA0626 | saRNA mechanism and function | 18 |
p21 | saRNA0622 | saRNA mechanism and function | 20 |
p21 | saRNA0838 | saRNA for anti-cancer/metastasis | 3 |
p21 | saRNA0839 | saRNA for anti-cancer/metastasis | 4.1 |
p21 | saRNA0841 | saRNA for anti-cancer/metastasis | 3.3 |
p21 | saRNA0842 | saRNA for anti-cancer/metastasis | 4.5 |
p21 | saRNA0967 | saRNA activation application | 2.7 |
p21 | saRNA0968 | saRNA activation application | 1.2 |
p21 | saRNA0969 | saRNA activation application | 2.4 |
p21 | saRNA0970 | saRNA activation application | 1 |
p21 | saRNA1693 | saRNA for anti-cancer | 12.5 |
p21 | saRNA1697 | saRNA for anti-cancer | 10.1 |
p21 | saRNA1706 | saRNA for anti-cancer | 13.1 |
p21 | saRNA1702 | saRNA for anti-cancer | 7.5 |
p21 | saRNA0755 | saRNA mechanism and function | 6.5 |
p21 | saRNA0757 | saRNA mechanism and function | 4.3 |
p21 | saRNA0761 | saRNA mechanism and function | 4.1 |
p21 | saRNA0763 | saRNA mechanism and function | 5 |
TP53 | saRNA0229 | saRNA for anti-cancer/metastasis | High |
TP53 | saRNA0230 | saRNA for anti-cancer/metastasis | High |
TP53 | saRNA0225 | saRNA for anti-cancer/metastasis | 4 |
TP53 | saRNA0227 | saRNA for anti-cancer/metastasis | 3.8 |
TP53 | saRNA0039 | RNA activation | 2 |
TP53 | saRNA0063 | RNA activation | 2.2 |
PAWR | saRNA1557 | saRNA for anti-cancer/metastasis | 3.2 |
PAWR | saRNA1558 | saRNA for anti-cancer/metastasis | 4 |
PAWR | saRNA1559 | saRNA for anti-cancer/metastasis | 3 |
PAWR | saRNA1543 | saRNA for anti-cancer/metastasis | 3.4 |
PAWR | saRNA1091 | RNA activation and apoptosis | 3 |
PAWR | saRNA1094 | RNA activation and apoptosis | 3.25 |
PAWR | saRNA1096 | RNA activation and apoptosis | 2.5 |
PAWR | saRNA1092 | RNA activation and apoptosis | 1 |
POMC | saRNA0335 | siRNA design for RNA activation | 2.66 |
POMC | saRNA0359 | siRNA design for RNA activation | 1.3 |
OCT4 (POU5F1) | saRNA1989 | saRNA activation application | 3 |
OCT4 (POU5F1) | saRNA1990 | saRNA activation application | 1.8 |
OCT4 (POU5F1) | saRNA1991 | saRNA activation application | 1.8 |
OCT4 (POU5F1) | saRNA1968 | saRNA activation application | 2.3 |
PR | saRNA1498 | saRNA chemical modification | Very high |
PR | saRNA1499 | saRNA chemical modification | Very high |
PR | saRNA1500 | saRNA chemical modification | Very high |
PR | saRNA1501 | saRNA chemical modification | Very high |
PR | saRNA1502 | saRNA chemical modification | Very high |
PR | saRNA0903 | RNA activation | 4.2 |
PR | saRNA0904 | RNA activation | 5.1 |
PR | saRNA0905 | RNA activation | 3 |
PR | saRNA0906 | RNA activation | 2.5 |
PR | saRNA0899 | RNA activation | 7.5 |
PR | saRNA0900 | RNA activation | 6 |
PR | saRNA0901 | RNA activation | 6 |
PR | saRNA0515 | saRNA mechanism and function | 3.8 |
PR | saRNA0516 | saRNA mechanism and function | 3.8 |
PR | saRNA0517 | saRNA mechanism and function | 5.1 |
PR | saRNA0518 | saRNA mechanism and function | 3.5 |
PTEN | saRNA0769 | saRNA for anti-cancer/metastasis | 0.69 |
PTEN | saRNA0770 | saRNA for anti-cancer/metastasis | 0.61 |
PTEN | saRNA0771 | saRNA for anti-cancer/metastasis | 0.29 |
PTEN | saRNA0772 | saRNA for anti-cancer/metastasis | 0.43 |
RECK | saRNA1061 | saRNA mechanism and function | Very high |
RECK | saRNA1062 | saRNA mechanism and function | Very high |
RECK | saRNA1063 | saRNA mechanism and function | Very high |
RECK | saRNA1064 | saRNA mechanism and function | Very high |
RECK | saRNA1044 | saRNA mechanism and function | Very high |
RECK | saRNA1041 | saRNA mechanism and function | 2.25 |
RECK | saRNA1020 | saRNA mechanism and function | 2 |
RHO | saRNA0341 | saRNA mechanism and function | 1.84 |
RHO | saRNA0368 | saRNA mechanism and function | 0.85 |
RHO | saRNA0370 | saRNA mechanism and function | 0.84 |
SOX2 | saRNA0008 | saRNA mechanism and function | 3150 |
TRPV5 | saRNA1068 | saRNA activation application | 32 |
TRPV5 | saRNA1075 | saRNA activation application | 11 |
TRPV5 | saRNA1079 | saRNA activation application | 9 |
TRPV5 | saRNA1080 | saRNA activation application | 9 |
VEGF | saRNA0028 | saRNA activation application | 4 |
VEGF | saRNA0040 | saRNA activation application | 5.2 |
VEGF | saRNA0041 | saRNA activation application | 3 |
VEGF | saRNA0064 | saRNA activation application | 2 |
VEGF | saRNA1104 | saRNA activation application | 10 |
VEGF | saRNA1105 | saRNA activation application | 40 |
VEGF | saRNA1106 | saRNA activation application | 1.9 |
VEGF | saRNA1587 | saRNA activation application | 4 |
VEGF | saRNA1588 | saRNA activation application | 1 |
VEGF | saRNA1589 | saRNA activation application | 2.2 |
VEGF | saRNA1699 | saRNA activation application | 4 |
VETZ | saRNA1116 | saRNA for anti-cancer/metastasis | 6.3 |
VETZ | saRNA1117 | saRNA for anti-cancer/metastasis | 7.2 |
VETZ | saRNA1118 | saRNA for anti-cancer/metastasis | 8.3 |
VETZ | saRNA1110 | saRNA for anti-cancer/metastasis | 7.5 |
WT1 | saRNA0042 | saRNA mechanism and function | 0.8 |
WT1 | saRNA0066 | saRNA mechanism and function | 2.6 |
WT1 | saRNA0635 | saRNA mechanism and function | 2.4 |
WT1 | saRNA0636 | saRNA mechanism and function | 1 |
RUNX3 | saRNA1001 | saRNA mechanism and function | High |
RUNX3 | saRNA1002 | saRNA mechanism and function | High |
LRIG1 | saRNA1003 | saRNA mechanism and function | 2 |